Loading...
Loading...
On CNBC's "Fast Money Halftime Report," Joe Terranova discussed he recent buys in Abbvie ABBV.
Terranova believes the Allergan integration going well and with clarity surrounding the election he wanted to redeploy money in the health care sector.
His reasons for buying into Abbvie include:
- Recent strong positive momentum
- Quality earnings report that it exhibited earlier in the month.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in